Vol. 80 No. 2 (2026)

Published 17. April 2026
Gastroenterologie a hepatologie

HEPATOLOGY

Full Issue
PDF (Czech)

Editorial

Lubomir Skladany (Autor)
91
Editorial 2/2026
PDF (Czech)

Review article

Tomas Nesnidal, Sona Frankova (Autor)
98–103
Benefits and risks of HCV cure
PDF (Czech)
Svetlana Adamcova Selcanova, Daniela Zilincanova, Lubomir Skladany (Autor)
104–110
Donation after circulatory death (DCD): the need to implement a program in Slovakia
PDF (Czech)

Original article

Daniela Zilincanova, Svetlana Adamcova Selcanova, Daniela Havaj, Karolina Sulejova, Natalia Kubanek, Michaela Mihokova, Miroslav Vybostok, Michal Zilincan, Roman Zahorec, Peter Jarčuška, Lubomir Skladany (Autor)
111–117
Neutrophil-to-lymphocyte ratio reflects inflammatory phenotypes of alcohol-associated hepatitis: differences between mild and severe dis­ease
PDF

Case report

Natalia Kubanek, Svetlana Adamcova Selcanova, Daniela Zilincanova, Karolina Kristina Sulejova, Daniel Jan Havaj, Adam Halaj, Tomas Koller, Lubomir Skladany (Autor)
118–123
A rare cause of headache in a liver transplant patient – a case report
PDF (Czech)

Guidelines

Petr Husa, Jan Sperl, Petr Urbanek, Sona Frankova (Autor)
124–143
Dia­gnosis and therapy of hepatitis B virus infection: Czech national guidelines
PDF (Czech)

Original article

Salikhat Dibraeva, Naida Iminova, Ilmuriyat Atasheva, Ravzanat Abdulgamidova, Rukizhat Aigunova, Karina Magomedova, Maryam Abakarova (Autor)
144–149
Impact of successful iron deficiency anemia correction with iron carboxymaltose on quality of life, treatment adherence, and exacerbation frequency in inflammatory bowel dis­ease patients
PDF

Review article

Petra Hlauskova, Karel Urbanek (Autor)
150–158
Potential therapeutic targets for the treatment of inflammatory bowel dis­eases
PDF (Czech)

Drug profile

Karel Urbanek (Autor)
161–169
Milestones in the research, development, and therapeutic use of infliximab
PDF (Czech)

Comments

170–172
The selection from international journals 2/2026
PDF (Czech)

Kvíz z klinické praxe

Ivana Rucklova (Autor)
173
Správná odpověď na předchozí kvíz
PDF (Czech)

Commercially supported communications

Jan Kulhavy (Autor)
175–177
Subcutaneous infliximab – improving treatment outcomes for patients with IBD
PDF (Czech)
Michaela Bachrata, Jan Kulhavy (Autor)
178–181
Three different approaches to subcutaneous infliximab: an in-depth look
PDF (Czech)
Michaela Bachrata (Autor)
183–185
Mapping the treatment landscape for ulcerative colitis in the era of IL-23 inhibitors
PDF (Czech)